文献速递腹部US

小肝细胞癌(≤30 mm)超声造影增强模式与临床病理特征的相关性

Enhancement patterns of small hepatocellular carcinoma (≤ 30 mm) on contrast-enhanced ultrasound: Correlation with clinicopathologic characteristics.
PubMed 文献 · Eur J Radiol · 2020-10-08

回顾性纳入346例患者372个经病理证实的小肝细胞癌(≤30 mm),分析超声造影动脉期高增强和门静脉/延迟期廓清与临床病理特征的相关性。93.3%的病灶表现为动脉期高增强,与肿瘤分化程度相关;79.3%出现廓清,多因素分析仅肿瘤大小与廓清独立相关。

要点

  • 93.3%的小肝细胞癌(≤30 mm)在超声造影动脉期表现为高增强,中/低分化者高增强比例显著高于高分化者(96.2% vs 58.6%)。
  • 79.3%的小肝细胞癌在门静脉/延迟期出现廓清,多因素分析显示仅肿瘤大小与廓清独立相关(OR=2.335,P=0.006)。
  • 20-30 mm的病灶较≤20 mm者廓清比例更高,阅片时需结合大小评估廓清表现。

关键影像表现/征象

  • 372个病灶中347个(93.3%)表现为动脉期高增强。
  • 372个病灶中295个(79.3%)在门静脉/延迟期出现廓清。

诊断标准与关键数值

  • 动脉期高增强与肿瘤分化程度相关(OR=10.336,P=0.000);中/低分化者较高分化者更易出现动脉期高增强(96.2% vs 58.6%,P<0.001)。
  • 单因素分析显示廓清与血清PIVKA-II水平、肿瘤大小、肿瘤分化程度及微血管侵犯相关(P<0.05)。
  • 多因素Logistic回归显示仅肿瘤大小与廓清显著相关(OR=2.335,P=0.006);20-30 mm病灶较≤20 mm病灶廓清比例更高。

临床应用与阅片要点

  • 阅片时注意小肝细胞癌动脉期高增强比例高,但高分化者也可不出现高增强(仅58.6%),需结合其他征象。
  • 肿瘤大小与廓清独立相关,对20-30 mm病灶应更仔细评估门静脉/延迟期廓清。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To analyze the correlation between enhancement patterns of small hepatic carcinomas (HCCs; ≤ 30 mm) on contrast-enhanced ultrasound (CEUS) and the clinicopathologic characteristics.

METHODS: The retrospective study included 346 inpatients (288 males and 58 females) with 372 pathologically confirmed small HCCs between January 2017 and December 2018. All patients underwent CEUS examination before pathological examination. Statistical analysis was used to determine the correlation between enhancement patterns of small HCCs on CEUS and clinicopathologic characteristics including serum alpha-feto-protein level, protein induced by vitamin K absence or antagonist-II (PIVKA-II) level, primary or recurrent HCC condition, tumor number, tumor differentiation, tumor size, liver background and microvascular invasion (MVI).

RESULTS: Three hundred forty-seven out of 372 (93.3 %) HCCs manifested arterial phase hyper-enhancement (APHE). The arterial enhancement patterns were correlated with the tumor differentiation (odds ratio = 10.336, P = 0.000). Moderately- or poorly-differentiated HCCs were more likely to display APHE than well-differentiated HCCs (96.2 % vs 58.6 %, P < 0.001). Two hundred ninety-five of 372 (79.3 %) HCCs showed washout in the portal venous/late phase. Washout was correlated with serum PIVKA-II level, tumor size, tumor differentiation, and MVI on univariate analysis (P < 0.05). Logistic regression analysis revealed that only tumor size was significantly associated with washout of small HCCs (odds ratio = 2.335, P = 0.006). Large HCCs (20-30 mm) displayed a higher proportion of washout compared with that of HCCs ≤ 20 mm.

CONCLUSIONS: Enhancement patterns of small HCCs on CEUS were significantly correlated with tumor size and tumor differentiation among all clinicopathologic characteristics.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Fan PL, Ding H, Mao F, et al. Enhancement patterns of small hepatocellular carcinoma (≤ 30 mm) on contrast-enhanced ultrasound: Correlation with clinicopathologic characteristics. Eur J Radiol. 2020. PMID: 33069987. doi:10.1016/j.ejrad.2020.109341

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。